Brian Tanquilut
Stock Analyst at Jefferies
(4.22)
# 442
Out of 5,090 analysts
136
Total ratings
61.22%
Success rate
11.39%
Average return
Main Sectors:
Stocks Rated by Brian Tanquilut
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Maintains: Buy | $485 → $525 | $486.70 | +7.87% | 9 | Oct 28, 2025 | |
| AVAH Aveanna Healthcare Holdings | Maintains: Buy | $11 → $13 | $9.31 | +34.26% | 4 | Oct 28, 2025 | |
| PNTG The Pennant Group | Initiates: Buy | $30 | $29.12 | +3.02% | 1 | Oct 24, 2025 | |
| MCK McKesson | Maintains: Buy | $820 → $900 | $808.62 | +11.30% | 4 | Oct 14, 2025 | |
| ODD Oddity Tech | Initiates: Buy | $78 | $45.29 | +72.22% | 1 | Sep 24, 2025 | |
| CHE Chemed | Upgrades: Buy | $490 → $550 | $421.97 | +30.34% | 2 | Sep 2, 2025 | |
| CYH Community Health Systems | Downgrades: Hold | $4.25 → $3 | $3.57 | -15.97% | 10 | Jul 24, 2025 | |
| CVS CVS Health | Maintains: Buy | $74 → $80 | $75.63 | +5.78% | 14 | Jun 30, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $140 → $150 | $198.83 | -24.56% | 4 | Feb 5, 2025 | |
| OPCH Option Care Health | Upgrades: Buy | $26 → $35 | $29.89 | +17.10% | 4 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $80 | $78.59 | +1.79% | 8 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8.25 → $9.5 | $9.33 | +1.82% | 4 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $41 → $27 | $16.26 | +66.05% | 5 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $10.78 | -25.79% | 9 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $245 → $265 | $258.39 | +2.56% | 6 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $9 | $6.48 | +38.89% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $22.12 | -59.31% | 10 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $35.79 | -49.71% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $140 → $155 | $182.51 | -15.07% | 6 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $85 | $210.00 | -59.52% | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $32 → $21 | $8.00 | +162.50% | 4 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $8.5 → $14 | $18.88 | -25.85% | 6 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $29.28 | +53.69% | 1 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.03 | +230.03% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $23.84 | +38.42% | 1 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $0.65 | +5,266.45% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $113.19 | -33.74% | 1 | Aug 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $47 | $15.47 | +203.81% | 5 | Jul 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $13 | $17.19 | -24.37% | 2 | Nov 1, 2017 |
HCA Healthcare
Oct 28, 2025
Maintains: Buy
Price Target: $485 → $525
Current: $486.70
Upside: +7.87%
Aveanna Healthcare Holdings
Oct 28, 2025
Maintains: Buy
Price Target: $11 → $13
Current: $9.31
Upside: +34.26%
The Pennant Group
Oct 24, 2025
Initiates: Buy
Price Target: $30
Current: $29.12
Upside: +3.02%
McKesson
Oct 14, 2025
Maintains: Buy
Price Target: $820 → $900
Current: $808.62
Upside: +11.30%
Oddity Tech
Sep 24, 2025
Initiates: Buy
Price Target: $78
Current: $45.29
Upside: +72.22%
Chemed
Sep 2, 2025
Upgrades: Buy
Price Target: $490 → $550
Current: $421.97
Upside: +30.34%
Community Health Systems
Jul 24, 2025
Downgrades: Hold
Price Target: $4.25 → $3
Current: $3.57
Upside: -15.97%
CVS Health
Jun 30, 2025
Maintains: Buy
Price Target: $74 → $80
Current: $75.63
Upside: +5.78%
Cardinal Health
Feb 5, 2025
Upgrades: Buy
Price Target: $140 → $150
Current: $198.83
Upside: -24.56%
Option Care Health
Jan 23, 2025
Upgrades: Buy
Price Target: $26 → $35
Current: $29.89
Upside: +17.10%
Jan 15, 2025
Maintains: Buy
Price Target: $100 → $80
Current: $78.59
Upside: +1.79%
Dec 9, 2024
Upgrades: Buy
Price Target: $8.25 → $9.5
Current: $9.33
Upside: +1.82%
Nov 13, 2024
Maintains: Hold
Price Target: $41 → $27
Current: $16.26
Upside: +66.05%
Oct 16, 2024
Initiates: Buy
Price Target: $8
Current: $10.78
Upside: -25.79%
Sep 23, 2024
Maintains: Buy
Price Target: $245 → $265
Current: $258.39
Upside: +2.56%
Mar 6, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $6.48
Upside: +38.89%
Mar 6, 2024
Maintains: Hold
Price Target: $10 → $9
Current: $22.12
Upside: -59.31%
Feb 20, 2024
Initiates: Buy
Price Target: $18
Current: $35.79
Upside: -49.71%
Feb 7, 2024
Upgrades: Buy
Price Target: $140 → $155
Current: $182.51
Upside: -15.07%
Nov 14, 2023
Maintains: Buy
Price Target: $95 → $85
Current: $210.00
Upside: -59.52%
Nov 3, 2023
Downgrades: Hold
Price Target: $32 → $21
Current: $8.00
Upside: +162.50%
Mar 24, 2023
Upgrades: Hold
Price Target: $8.5 → $14
Current: $18.88
Upside: -25.85%
Nov 7, 2022
Assumes: Buy
Price Target: $45
Current: $29.28
Upside: +53.69%
Aug 15, 2022
Initiates: Buy
Price Target: $10
Current: $3.03
Upside: +230.03%
Jan 3, 2022
Initiates: Buy
Price Target: $33
Current: $23.84
Upside: +38.42%
Oct 20, 2021
Initiates: Buy
Price Target: $35
Current: $0.65
Upside: +5,266.45%
Aug 21, 2018
Initiates: Buy
Price Target: $75
Current: $113.19
Upside: -33.74%
Jul 31, 2018
Maintains: Buy
Price Target: $44 → $47
Current: $15.47
Upside: +203.81%
Nov 1, 2017
Maintains: Buy
Price Target: $16 → $13
Current: $17.19
Upside: -24.37%